A NOVEL PHENOTYPIC METHOD TO DETERMINE FLUDARABINE TRIPHOSPHATE ACCUMULATION IN T-LYMPHOCYTES FROM HEMATOPOIETIC CELL TRANSPLANTATION PATIENTS

PURPOSE: Fludarabine is an integral anticancer agent for patients with chronic lymphocytic leukemia (CLL) and those receiving conditioning regimens prior to allogeneic hematopoietic cell transplantation (HCT). An individual’s response to fludarabine may be influenced by the amount of CD4(+) and CD8(...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Chemother Pharmacol
Main Authors: Woodahl, Erica L., Wang, Joanne, Heimfeld, Shelly, Sandmaier, Brenda M., O'Donnell, Paul V., Phillips, Brian, Risler, Linda, Blough, David K., McCune, Jeannine S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6708594/
https://ncbi.nlm.nih.gov/pubmed/18398611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-008-0748-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados